Matinas BioPharma Holdings, Inc.

MTNB XASE • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

1.5M

Short interest (Jul 15)

7.4%

Net Short (Jul 27 ): 37.7%

Borrow Fee

1.60%

↑ 57.9%

Available Shares

80K

↓ 75.7%

Price Chart

Company Overview

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Company Info

Exchange: XASE

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001582554

Asset Type: CS

Market Data

Market Cap: $1,546,454

Employees: 2

Status: Active

Short Interest

Current Borrow Fee 1.60%

Range: 0.75% - 1.65%

Available Shares 80K

Range: 0 - 80K

Recent Changes

Fee Change: ↑ 61.7%

Available Change: ↓ 68.1%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime